Although GM-CSF neutralization proved effective in ameliorating psoriasiform dermatitis, mice genetically deficient in GM-CSF surprisingly developed IMQPD that was as severe as that observed in wild-type controls. The gene discussed is CSF2; the disease is Psoriasiform dermatitis.